If your institution subscribes to this resource, and you don't have a MyAccess Profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
Vaccine for active immunization (as a three-shot series to protect against dengue disease caused by infection with virus serotypes 1–4 in children 9–16 years of age living in endemic areas and having a laboratory-confirmed previous infection)
Prophylaxis against dengue fever
Chapter 36. Immune Globulins and Vaccines > Dengue Virus Vaccine
eChapter 2018: The Goodman & Gilman Year in Review New and Noteworthy FDA Approvals